Table 1

Main demographic and clinical characteristics of the present series (30 patients)

Parameter

Value


Age (years)

57.13 ± 9.21

Female/male

24/6

Duration of disease (years)

9.43 ± 8.97

Number of of tender joints

16.46 ± 9.1

Number of swollen joints

6.83 ± 4.814

RF positivity

86.70%

Joint erosions

100%

Serum CRP (mg/dl)

3.85 ± 2.74

DAS 28

6.1 ± 1.025

HAQ

1.78 ± 0.422

Previous DMARDs

Methotrexate

30

Hydroxycloroquine

26

Sulfasalazine

18

Cyclosporin A

19

Gold (intramuscular)

3

Leflunomide

1

Azathioprine

1


Where applicable, values are expressed as ± standard deviation. CRP, C-reactive protein; DAS 28, Disease Activity Score; DMARD, disease-modifying antirheumatic drug; HAQ, Health Assessment Questionnaire; RF, rheumatoid factor.

Bobbio-Pallavicini et al. Arthritis Res Ther 2004 6:R264-R272   doi:10.1186/ar1173

Open Data